| 2010 |
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel J-P, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. July 2010;39(4):412-423. |
31 |
31 |
| 2008 |
Pothuaud L, Carceller P, Hans D. Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone. April 2008;42(4):775-787. |
20 |
19 |
| 2020 |
Ferrari S, Eastell R, Napoli N, Schwartz A, Hofbauer LC, Chines A, Wang A, Pannacciulli N, Cummings SR. Denosumab in postmenopausal women with osteoporosis and diabetes: subgroup analysis of FREEDOM and FREEDOM extension. Bone. May 2020;134:115268. |
2 |
0 |
| 2020 |
Ferrari S, Lewiecki EM, Butler PW, Kendler DL, Napoli N, Huang S, Crittenden DB, Pannacciulli N, Siris E, Binkley N. Favorable skeletal benefit/risk of long-term denosumab therapy: a virtual-twin analysis of fractures prevented relative to skeletal safety events observed. Bone. May 2020;134:115287. |
1 |
1 |
| 2022 |
Büchi AE, Feller M, Netzer S, Blum MR, Gonzalez Rodriguez E, Collet T-H, Del Giovane C, van Heemst D, Quinn T, Kearney PM, Westendorp RG, Gussekloo J, Mooijaart SP, Hans D, Bauer DC, Rodondi N, Aeberli D. Bone geometry in older adults with subclinical hypothyroidism upon levothyroxine therapy: a nested study within a randomized placebo controlled trial. Bone. August 2022;161:116404. |
0 |
0 |
| 2022 |
Farlay D, Falgayrac G, Ponçon C, Rizzo S, Cortet B, Chapurlat R, Penel G, Badoud I, Ammann P, Boivin G. Material and nanomechanical properties of bone structural units of cortical and trabecular iliac bone tissues from untreated postmenopausal osteoporotic women. Bone Rep. December 2022;17:101623. |
0 |
0 |
| 2020 |
Papageorgiou M, Föger-Samwald U, Wahl K, Kerschan-Schindl K, Pietschmann P. Age- and strain-related differences in bone microstructure and body composition during development in inbred male mouse strains. Calcif Tiss Int. April 2020;106(4):431-443. |
2 |
2 |
| 2020 |
Cardinal M, Dessain A, Roels T, Lafont S, Ominsky MS, Devogelaer J-P, Chappard D, Mabilleau G, Ammann P, Nyssen-Behets C, Manicourt DH. Sclerostin-antibody treatment decreases fracture rates in axial skeleton and improves the skeletal phenotype in growing oim/oim mice. Calcif Tiss Int. May 2020;106(5):494-508. |
2 |
2 |
| 2021 |
Shaik AR, Singh P, Shaik C, Kohli S, Vohora D, Ferrari SL. Metformin: is it the well wisher of bone beyond glycemic control in diabetes mellitus? Calcif Tiss Int. June 2021;108(6):693-707. |
0 |
0 |
| 2020 |
Chevalier C, Kieser S, Çolakoğlu M, Hadadi N, Brun J, Rigo D, Suárez-Zamorano N, Spiljar M, Fabbiano S, Busse B, Ivanišević J, Macpherson A, Bonnet N, Trajkovski M. Warmth prevents bone loss through the gut microbiota. Cell Metab. October 6, 2020;32(4):575. |
2 |
1 |
| 1999 |
Farshad M, Barbezat M, Flüeler P, Schmidlin F, Graber P, Niederer P. Material characterization of the pig kidney in relation with the biomechanical analysis of renal trauma. J Biomech. April 1999;32(4):417-425. |
14 |
12 |
| 2005 |
Snedeker JG, Barbezat M, Niederer P, Schmidlin FR, Farshad M. Strain energy density as a rupture criterion for the kidney: impact tests on porcine organs, finite element simulation, and a baseline comparison between human and porcine tissues. J Biomech. May 2005;38(5):993-1001. |
14 |
13 |
| 2005 |
Snedeker JG, Niederer P, Schmidlin FR, Farshad M, Demetropoulos CK, Lee JB, Yang KH. Strain-rate dependent material properties of the porcine and human kidney capsule. J Biomech. May 2005;38(5):1011-1021. |
16 |
11 |
| 2025 |
Rovas G, Reymond P, van Steenberghe M, Diaper J, Bikia V, Cikirikcioglu M, Habre W, Huber C, Stergiopulos N. Evaluation of a novel compliance-matching aortic graft in a swine model. J Biomech. April 2025;183:112629. |
0 |
0 |
| 2018 |
Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen J-EB, McClung M, Roux C, Törring O, Valter I, Wang AT, Brown JP. Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res. February 2018;33(2):190-198. |
35 |
27 |
| 2018 |
Biver E, Durosier-Izart C, Chevalley T, van Rietbergen B, Rizzoli R, Ferrari S. Evaluation of radius microstructure and areal bone mineral density improves fracture prediction in postmenopausal women. J Bone Miner Res. February 2018;33(2):328-337. |
22 |
18 |
| 2019 |
Ferrari S, Libanati C, Lin CJF, Brown JP, Cosman F, Czerwiński E, de Gregόrio LH, Malouf-Sierra J, Reginster J-Y, Wang A, Wagman RB, Lewiecki EM. Relationship between bone mineral density T-score and nonvertebral fracture risk over 10 years of denosumab treatment. J Bone Miner Res. June 2019;34(6):1033-1040. |
12 |
9 |
| 2020 |
Ferrari S. Zoledronate following denosumab discontinuation: partial reassurance but no confidence. J Bone Miner Res. July 2020;35(7):1205-1206. |
2 |
2 |
| 2020 |
Cosman F, Lewiecki EM, Ebeling PR, Hesse E, Napoli N, Matsumoto T, Crittenden DB, Rojeski M, Yang W, Libanati C, Ferrari S. T‐score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trial. J Bone Miner Res. July 2020;35(7):1333-1342. |
1 |
1 |
| 2021 |
Gerbaix M, Ammann P, Ferrari S. Mechanically driven counter‐regulation of cortical bone formation in response to sclerostin‐neutralizing antibodies. J Bone Miner Res. February 2021;36(2):385-399. |
1 |
1 |
| 2021 |
Fusaro M, Cozzolino M, Plebani M, Iervasi G, Ketteler M, Gallieni M, Aghi A, Locatelli F, Cunningham J, Salam S, Zaninotto M, Ravera M, Russo D, Mereu MC, Giannini S, Brandi ML, Ferrari S, Sella S, Egan CG, Bellasi A, Lullo LD, Tripepi G, Nickolas T. Sevelamer use, vitamin K levels, vascular calcifications, and vertebral fractures in hemodialysis patients: results from the VIKI study. J Bone Miner Res. March 2021;36(3):500-509. |
0 |
0 |
| 2022 |
Bégin M-J, Audet M-C, Chevalley T, Portela M, Padlina I, Hannouche D, Lorenzini KI, Meier R, Peter R, Uebelhart B, Rizzoli R, Ferrari S, Biver E. Fracture risk following an atypical femoral fracture. J Bone Miner Res. January 2022;37(1):87-94. |
1 |
1 |
| 2022 |
Whittier DE, Samelson EJ, Hannan MT, Burt LA, Hanley DA, Biver E, Szulc P, Sornay-Rendu E, Merle B, Chapurlat R, Lespessailles E, Wong AKO, Goltzman D, Khosla S, Ferrari S, Bouxsein ML, Kiel DP, Boyd SK. Bone microarchitecture phenotypes identified in older adults are associated with different levels of osteoporotic fracture risk. J Bone Miner Res. March 2022;37(3):428-439. |
7 |
3 |
| 2022 |
Minisola S, Arnold A, Belaya Z, Brandi ML, Clarke BL, Hannan FM, Hofbauer LC, Insogna KL, Lacroix A, Liberman U, Palermo A, Pepe J, Rizzoli R, Wermers R, Thakker RV. Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism. J Bone Miner Res. November 2022;37(11):2315-2329. |
5 |
1 |
| 2023 |
Bilezikian JP, Fraenkel M, Tripto-Shkolnik L, Rizzoli R, Siris E. In memoriam: Uri A. Liberman, 1935–2022. J Bone Miner Res. April 2023;38(4):455-456. |
0 |
0 |
| 2023 |
Whittier DE, Samelson EJ, Hannan MT, Burt LA, Hanley DA, Biver E, Szulc P, Sornay-Rendu E, Merle B, Chapurlat R, Lespessailles E, Wong AKO, Goltzman D, Khosla S, Ferrari S, Bouxsein ML, Kiel DP, Boyd SK. A fracture risk assessment tool for high resolution peripheral quantitative computed tomography. J Bone Miner Res. September 2023;38(9):1234-1244. |
1 |
1 |
| 2019 |
Samelson EJ, Broe KE, Xu H, Yang L, Boyd S, Biver E, Szulc P, Adachi J, Amin S, Atkinson E, Berger C, Burt L, Chapurlat R, Chevalley T, Ferrari S, Goltzman D, Hanley DA, Hannan MT, Khosla S, Liu C-T, Lorentzon M, Mellstrom D, Merle B, Nethander M, Rizzoli R, Sornay-Rendu E, Van Rietbergen B, Sundh D, Wong AKO, Ohlsson C, Demissie S, Kiel DP, Bouxsein ML. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diabetes Endocrinol. January 2019;7(1):34-43. |
65 |
34 |
| 2017 |
Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL; IOF Bone and Diabetes Working Group. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. April 2017;13(4):208-219. |
37 |
33 |
| 2016 |
Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CAF, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A. Romosozumab treatment in postmenopausal women with osteoporosis. NEJM. October 20, 2016;375(16):1532-1543. |
91 |
75 |
| 2003 |
Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int. March 2003;14(suppl 3):S13-S18. |
67 |
67 |
| 2007 |
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg M-A, La Croix A, McCloskey E, Mellstrom D, Melton LJ, Pols H, Reeve J, Sanders K, Schott A-M, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. August 2007;18(8):1033-1046. |
66 |
41 |
| 2008 |
Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster J-Y, Borgstrom F, Rizzoli R; European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. April 2008;19(4):399-428. |
16 |
10 |
| 2011 |
Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV. Interpretation and use of FRAX in clinical practice. Osteoporos Int. September 2011;22(9):2395-2411. |
32 |
20 |
| 2012 |
Rizzoli R, Chapurlat RD, Laroche J-M, Krieg MA, Thomas T, Frieling I, Boutroy S, Laib A, Bock O, Felsenberg D. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Osteoporos Int. January 2012;23(1):305-315. |
12 |
11 |
| 2017 |
Harvey NCW, McCloskey EV, Mitchell PJ, Dawson-Hughes B, Pierroz DD, Reginster J-Y, Rizzoli R, Cooper C, Kanis JA. Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int. May 2017;28(5):1507-1529. |
15 |
5 |
| 2020 |
Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster J-Y. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. January 2020;31(1):1-12. |
12 |
7 |
| 2020 |
Kanis JA, Cooper C, Rizzoli R, Reginster J-Y; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO); Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). Correction to “European guidance for the diagnosis and management of osteoporosis in postmenopausal women”. Osteoporos Int. January 2020;31(1):209-209. |
0 |
0 |
| 2020 |
Zürcher SJ, Borter N, Kränzlin M, Neyer P, Meyer U, Rizzoli R, Kriemler S. Relationship between bone mineral content and bone turnover markers, sex hormones and calciotropic hormones in pre- and early pubertal children. Osteoporos Int. February 2020;31(2):335-349. |
0 |
0 |
| 2020 |
Bouxsein ML, Zysset P, Glüer CC, McClung M, Biver E, Pierroz DD, Ferrari SL; IOF Working Group on Hip Bone Strength as a Therapeutic Target. Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk. Osteoporos Int. March 2020;31(3):393-408. |
7 |
6 |
| 2020 |
Geiker NRW, Mølgaard C, Iuliano S, Rizzoli R, Manios Y, van Loon LJC, Lecerf J-M, Moschonis G, Reginster J-Y, Givens I, Astrup A. Impact of whole dairy matrix on musculoskeletal health and aging: current knowledge and research gaps [published correction appears in Osteoporos Int. April 2020;31(4):795-795]. Osteoporos Int. April 2020;31(4):601-615. |
0 |
0 |
| 2020 |
Javaid MK, Sami A, Lems W, Mitchell P, Thomas T, Singer A, Speerin R, Fujita M, Pierroz DD, Akesson K, Halbout P, Ferrari S, Cooper C. A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int. July 2020;31(7):1193-1204. |
6 |
2 |
| 2021 |
Lems WF, Paccou J, Zhang J, Fuggle NR, Chandran M, Harvey NC, Cooper C, Javaid K, Ferrari S, Akesson KE; International Osteoporosis Foundation Fracture Working Group. Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services. Osteoporos Int. March 2021;32(3):399-411. |
3 |
3 |
| 2021 |
Cooper C, Halbout P, Dawson-Hughes B, Harvey NC, Kanis JA, Reginster J-Y, Rizzoli R. In memory of Harry K Genant. Osteoporos Int. March 2021;32(3):607-608. |
0 |
0 |
| 2016 |
Langdahl B, Ferrari S, Dempster DW. Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. Ther Adv Musculoskel Dis. December 2016;8(6):225-235. |
42 |
38 |